ArticleFrontiers in pharmacology2015

Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity.

Yuhei Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.